Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan
Horizon Therapeutics plc announced Paul Hoelscher, executive vice president, chief financial officer, and continue as an advisor to the Company through May 2023. Aaron Cox, who was named executive vice president, finance, will succeed Mr. Hoelscher. “Paul has served as Horizon’s CFO since 2014 and has been critical in guiding......